Multi-Component Behavioral Intervention for Complex Patients with CVD Risk
针对具有 CVD 风险的复杂患者的多成分行为干预
基本信息
- 批准号:9434534
- 负责人:
- 金额:$ 3.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAddressAdherenceAdultAgeAlcohol consumptionAlcohol dependenceAnxietyBehaviorBehavior TherapyBehavioralBlood PressureCaliforniaCardiovascular DiseasesCaringCause of DeathCharacteristicsCholesterolChronicChronic DiseaseClinicalCommunicationComorbidityComplexDiabetes MellitusDisease ManagementEffectiveness of InterventionsEnrollmentGlycosylated hemoglobin AGoalsHealthHealth ResourcesHealth StatusHealth behaviorHealth systemHeart DiseasesHyperlipidemiaHypertensionIndividualInterventionLDL Cholesterol LipoproteinsMail OrderMeasuresMedicaidMedicalMedicareMental DepressionMental HealthModelingMotivationOutcomeOutpatientsPatient AdmissionPatientsPharmaceutical PreparationsPharmacy facilityPopulationPreventionPrimary Health CareProviderRandomizedResearchRiskRisk FactorsRisk ReductionSelf CareSelf ManagementSystemTreatment EfficacyVisitalcohol misusearmbehavioral healthcardiovascular disorder riskcare deliverycare systemscostdesigndiet and exerciseevidence based guidelinesfallsgood diethealth care service utilizationhigh riskimprovedmedication compliancemembermultiple chronic conditionsnovel strategiespatient orientedpersonalized careprimary outcomeprogramspublic health relevancerandomized trialresponsescreeningskillssubclinical depressiontherapy designtreatment as usual
项目摘要
DESCRIPTION (provided by applicant): Cardiovascular disease (CVD) is the leading cause of death in the U.S. Despite the availability of evidence-based guidelines and efficacious therapies, however, many patients do not achieve the full benefit of CVD risk reduction. In particular, complex patients (defined as those patients who do not respond to current disease management approaches) with multiple concurrent chronic conditions represent a key segment of the population that would benefit from new approaches to care. In response to PA-12-024: Behavioral Interventions to Address Multiple Chronic Conditions in Primary Care, which seeks "practical interventions...to modify behaviors using a common approach" among patients with multiple co-morbidities, we propose to implement and rigorously evaluate an integrated behavioral intervention designed to improve a core set of chronic disease self-management skills and to overcome common barriers to care engagement encountered by this increasingly important segment of the U.S. adult primary care population. This randomized trial will be conducted within Kaiser Permanente Northern California (KPNC), an integrated care delivery system serving over 3.2 million members, including patients insured through Medicare and state Medicaid programs. We will evaluate our intervention in 3 KPNC primary care practices by enrolling 576 complex patients who have persistently (e 2 years) uncontrolled CVD risk factors (e.g. hypertension, hyperlipidemia, diabetes) despite being enrolled in a CVD disease management program. This behavioral intervention is designed to activate and engage patients, identify potentially hidden barriers to care such as alcohol misuse or sub-clinical depression, and to develop individualized care plans that are designed to catalyze more effective primary care management. Randomization will be at the patient-level, blocked by primary care provider, with the following aims: 1) To examine the impact of (intervention + usual care) vs. (usual care alone) on control of systolic blood pressure [primary outcome], LDL cholesterol, Framingham Risk Score (if no baseline CVD), and HbA1c (if with diabetes) at 12 months; 2) To examine effectiveness of (intervention + usual care) vs. (usual care alone) on proximal outcomes (patient activation, medication adherence, and mental health status) after 3 and 12 months, and 3) To identify baseline patient factors associated with more vs. less successful clinical response among intervention arm patients. By focusing on core health skills and care barriers, this patient-focused intervention seeks to enable complex patients to become more effective agents of their own care and to thereby achieve similar clinical benefits as less complex patients.
描述(由申请人提供):心血管疾病(CVD)是美国的主要死亡原因。尽管有循证指南和有效的治疗方法,但许多患者并未获得CVD风险降低的全部益处。特别是,患有多种并发慢性疾病的复杂患者(定义为对当前疾病管理方法无反应的患者)代表了受益于新护理方法的关键人群。在回应PA-12-024:行为干预,以解决多种慢性疾病的初级保健,其中寻求“实际干预...在患有多种合并症的患者中,我们建议实施并严格评估一种综合行为干预措施,旨在改善一套核心的慢性病自我管理技能,并克服美国成人初级保健人群中越来越重要的部分所遇到的共同障碍。这项随机试验将在Kaiser Permanente北方加州(KPNC)进行,这是一个综合护理提供系统,为320多万成员提供服务,包括通过医疗保险和州医疗补助计划投保的患者。我们将通过招募576名复杂患者来评估我们在3种KPNC初级保健实践中的干预措施,这些患者尽管参加了CVD疾病管理计划,但仍具有持续(e2年)不受控制的CVD风险因素(例如高血压,高脂血症,糖尿病)。这种行为干预旨在激活和吸引患者,识别潜在的隐藏障碍,如酒精滥用或亚临床抑郁症,并制定个性化的护理计划,旨在促进更有效的初级保健管理。随机化将在患者层面进行,由初级保健提供者阻止,目的如下:1)检查(干预+常规护理)与(仅常规治疗)控制收缩压[主要结局]、LDL胆固醇、脆性风险评分(如果无基线CVD)和HbA 1c(如果患有糖尿病)12个月时;(2)检查有效性(干预+常规护理)与(仅常规治疗)对近端结局的影响(患者激活、药物依从性和心理健康状态),和3)确定与干预组患者中更多与更少成功临床应答相关的基线患者因素。通过关注核心健康技能和护理障碍,这种以患者为中心的干预措施旨在使复杂患者成为更有效的自我护理代理人,从而实现与复杂程度较低的患者相似的临床获益。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Engaging patients in population-based chronic disease management: A qualitative study of barriers and intervention opportunities.
- DOI:10.1016/j.pec.2021.04.038
- 发表时间:2022-01
- 期刊:
- 影响因子:3.5
- 作者:Fang A;Abdelgadir D;Gopalan A;Ross T;Uratsu CS;Sterling SA;Grant RW;Iturralde E
- 通讯作者:Iturralde E
CREATE Wellness: A multi-component behavioral intervention for patients not responding to traditional Cardiovascular disease management.
- DOI:10.1016/j.conctc.2017.10.001
- 发表时间:2017-12
- 期刊:
- 影响因子:1.5
- 作者:Miller-Rosales C;Sterling SA;Wood SB;Ross T;Makki M;Zamudio C;Kane IM;Richardson MC;Samayoa C;Charvat-Aguilar N;Lu WY;Vo M;Whelan K;Uratsu CS;Grant RW
- 通讯作者:Grant RW
Building a Career as a Delivery Science Researcher in a Changing Health Care Landscape.
在不断变化的医疗保健环境中建立交付科学研究人员的职业生涯。
- DOI:10.1007/s11606-015-3178-9
- 发表时间:2015
- 期刊:
- 影响因子:5.7
- 作者:Grant,RichardW;Schmittdiel,JulieA
- 通讯作者:Schmittdiel,JulieA
The Diabetes Telephone Study: Design and challenges of a pragmatic cluster randomized trial to improve diabetic peripheral neuropathy treatment.
- DOI:10.1177/1740774516631530
- 发表时间:2016-06
- 期刊:
- 影响因子:0
- 作者:Adams AS;Bayliss EA;Schmittdiel JA;Altschuler A;Dyer W;Neugebauer R;Jaffe M;Young JD;Kim E;Grant RW;Diabetes Telephone Study Team
- 通讯作者:Diabetes Telephone Study Team
Overcoming barriers to diabetic polyneuropathy management in primary care.
克服初级保健中糖尿病多发性神经病管理的障碍。
- DOI:10.1016/j.hjdsi.2016.10.003
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Adams,AlyceS;Callaghan,Brian;Grant,RichardW
- 通讯作者:Grant,RichardW
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD W GRANT其他文献
RICHARD W GRANT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD W GRANT', 18)}}的其他基金
Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Prescribing in High-Risk Older Patients with Type 2 Diabetes
基于连续血糖监测的干预措施为高危老年 2 型糖尿病患者安全处方胰岛素的实用临床试验
- 批准号:
10559099 - 财政年份:2023
- 资助金额:
$ 3.74万 - 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
- 批准号:
10026740 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
- 批准号:
10237364 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
- 批准号:
10837668 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
Race/ethnic Differences Among Older Patients with Type 2 Diabetes at Risk for Hypoglycemia
有低血糖风险的老年 2 型糖尿病患者的种族/民族差异
- 批准号:
10318875 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
- 批准号:
10395599 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
- 批准号:
10633067 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
Administrative Supplement (PA-20-272) to Expand Safe Insulin De-Prescribing (R01 Award) to include Patients with ADRD and Their Caregivers
行政补充文件 (PA-20-272) 将安全胰岛素取消处方(R01 奖)扩大到包括 ADRD 患者及其护理人员
- 批准号:
10492857 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
Differences Among Older English and Spanish-speaking Latinx Patients with Type 2 Diabetes at Risk for Hypoglycemia (Admin Supp)
患有低血糖风险的老年英语和西班牙语拉丁裔 2 型糖尿病患者之间的差异(管理补充)
- 批准号:
10598945 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
Care System Analytics to Support Primary Care Patients with Complex Medical and Social Needs
护理系统分析支持具有复杂医疗和社会需求的初级保健患者
- 批准号:
10013216 - 财政年份:2019
- 资助金额:
$ 3.74万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 3.74万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 3.74万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 3.74万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 3.74万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 3.74万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 3.74万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 3.74万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 3.74万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 3.74万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 3.74万 - 项目类别: